WeissLaw LLP: Ra Medical Systems, Inc. is the Subject of a Legal Investigation

Date : 10/04/2019 @ 10:20PM
Source : PR Newswire (US)
Stock : Ra Medical Systems Inc (RMED)
Quote : 1.55  0.0 (0.00%) @ 12:00AM

WeissLaw LLP: Ra Medical Systems, Inc. is the Subject of a Legal Investigation

Ra Medical Systems (NYSE:RMED)
Historical Stock Chart

2 Months : From Sep 2019 to Nov 2019

Click Here for more Ra Medical Systems Charts.

NEW YORK, Oct. 4, 2019 /PRNewswire/ -- WeissLaw LLP, a national class action and shareholders' rights law firm with offices in New York, Los Angeles and Atlanta, announces an investigation of Ra Medical Systems, Inc. (NYSE: RMED) ("RMED," or the "Company").

WeissLaw LLP (PRNewsfoto/WeissLaw LLP)

If you own RMED shares and wish to discuss this investigation or have any questions concerning this notice or your rights or interests, visit our website:

http://www.weisslawllp.com/ra-medical-systems-inc/

Or please contact:

Joshua Rubin, Esq.
WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY  10036
(212) 682-3025
(888) 593-4771
stockinfo@weisslawllp.com

The investigation focuses on possible breaches of fiduciary duty and violations of federal securities laws by the RMED Board of Directors for the alleged dissemination of a materially false and/or misleading Registration and Proxy Statement in connection with its September 2018 initial public offering ("IPO").  Notably, on March 14, 2019, the Company reported revenue of approximately $2 million for the fourth quarter of 2018, missing its projections by $710,000, or 35%.  On that news, RMED's share price plummeted from the previous trading day's price of $6.53 to trade as low as $3.76 on March 15.  The share price continued its slide so that, merely a little more than a year after the Company's IPO, on October 3, 2019, RMED shares closed at $1.14, down approximately 94% from its $17.00 IPO price.  

WeissLaw is investigating whether RMED's Board breached its fiduciary duties to the Company and its shareholders by misrepresenting and/or failing to disclose material information about the Company and its operations.  Namely, that RMED: (i) did not have an adequately trained and qualified sales staff; (ii) could not reasonably support increases in its catheter production; and (iii) as a result, suffered delays and losses.  If you wish to discuss this investigation or have any questions concerning this notice or your rights or interests, please contact Joshua Rubin of WeissLaw LLP at (888)593-4771, or by e-mail at stockinfo@weisslawllp.com.  

WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties.  We have recovered over a billion dollars for defrauded clients. 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/weisslaw-llp-ra-medical-systems-inc-is-the-subject-of-a-legal-investigation-300931498.html

SOURCE WeissLaw LLP

Copyright 2019 PR Newswire

Latest RMED Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.